1. Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma. (March 2019) Authors: van Boxtel, W.; Locati, L.D.; van Engen-van Grunsven, A.C.H.; Bergamini, C.; Jonker, M.A.; Fiets, E.; Cavalieri, S.; Tooten, S.; Bos, E.; Quattrone, P.; Verhaegh, G.W.; Schalken, J.A.; Licitra, L.; van Herpen, C.M.L. Journal: European journal of cancer Issue: Volume 110(2019) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Treatment with cyclosporin and risks of graft rejection in male kidney and heart transplant recipients with non-O blood. Issue 6653 (8th October 1988) Authors: Hendriks, G. F.; van Steenberge, E. P.; Schreuder, G. M.; Wenting, G. J.; Mochtar, B.; Bos, E.; Simoons, M. L.; Balk, A. H.; Laird-Meeter, K.; Essed, C. E. Journal: BMJ Issue: Volume 297:Issue 6653(1988) Page Start: 888 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗